Selvan, Kavitha C.
Reicher, Joshua
Muelly, Michael
Kalra, Angad
Adegunsoye, Ayodeji
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (T32HL007605)
National Institutes of Health (K23HL146942)
Article History
Received: 25 September 2023
Accepted: 17 April 2024
First Online: 23 May 2024
Declarations
:
: We consulted extensively with Argus Institutional Review Board (IRB) who determined that our study did not need ethical approval. An IRB official waiver of ethical approval was granted from Argus IRB. The data protocols are in accordance with the ethical standards of our institution and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all participants included in this study.
: Not applicable.
: K.S. has no competing interests. J.R., M.M., and A.K. have a financial interest in IMVARIA Inc. A.A. has relationships with Genentech Inc., Inongen Inc., Medscape LLC, PatientMpower, Abbvie, and Boehringer Ingelheim Corp USA.